These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10676641)

  • 1. Single-site methylation within the p53 promoter region reduces gene expression in a reporter gene construct: possible in vivo relevance during tumorigenesis.
    Pogribny IP; Pogribna M; Christman JK; James SJ
    Cancer Res; 2000 Feb; 60(3):588-94. PubMed ID: 10676641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene.
    Schroeder M; Mass MJ
    Biochem Biophys Res Commun; 1997 Jun; 235(2):403-6. PubMed ID: 9199206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation of the human oxytocin receptor gene promoter regulates tissue-specific gene suppression.
    Kusui C; Kimura T; Ogita K; Nakamura H; Matsumura Y; Koyama M; Azuma C; Murata Y
    Biochem Biophys Res Commun; 2001 Dec; 289(3):681-6. PubMed ID: 11726201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide induces aberrant hypermethylation of Hic-1 in mouse embryonic fibroblasts lacking p53 gene.
    Tatemichi M; Hata H; Tazawa H; Nakadate T
    Anticancer Res; 2008; 28(4B):2101-8. PubMed ID: 18751382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.
    Mancini DN; Rodenhiser DI; Ainsworth PJ; O'Malley FP; Singh SM; Xing W; Archer TK
    Oncogene; 1998 Mar; 16(9):1161-9. PubMed ID: 9528858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A methylation-dependent DNA-binding activity recognising the methylated promoter region of the mouse Xist gene.
    Huntriss J; Lorenzi R; Purewal A; Monk M
    Biochem Biophys Res Commun; 1997 Jun; 235(3):730-8. PubMed ID: 9207230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methylation of non-CpG sequence in the promoter region on the expression of human synaptotagmin XI (syt11).
    Inoue S; Oishi M
    Gene; 2005 Mar; 348():123-34. PubMed ID: 15777718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53.
    Seike M; Gemma A; Hosoya Y; Hemmi S; Taniguchi Y; Fukuda Y; Yamanaka N; Kudoh S
    Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epigenetic mechanism regulates germ cell-specific expression of the porcine Deleted in Azoospermia-Like (DAZL) gene.
    Linher K; Cheung Q; Baker P; Bedecarrats G; Shiota K; Li J
    Differentiation; 2009 Apr; 77(4):335-49. PubMed ID: 19281782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation.
    Hanafusa T; Shinji T; Shiraha H; Nouso K; Iwasaki Y; Yumoto E; Ono T; Koide N
    BMC Cancer; 2005 Jan; 5():9. PubMed ID: 15661074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis.
    Esteller M; Risques RA; Toyota M; Capella G; Moreno V; Peinado MA; Baylin SB; Herman JG
    Cancer Res; 2001 Jun; 61(12):4689-92. PubMed ID: 11406538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenobarbital-induced hypermethylation of the p53 promoter region in the liver of Wistar rats].
    Kostka G; Urbanek-Olejnik K; Wiadrowska B; Bańkowski R
    Rocz Panstw Zakl Hig; 2008; 59(4):455-65. PubMed ID: 19227257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
    Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell growth- and P53-dependent transcriptional activity of the midkine promoter confers suicide gene expression in tumor cells.
    Yu L; Ugai S; O-Wang J; Namba M; Kadomatsu K; Muramatsu T; Matsubara S; Sakiyama S; Tagawa M
    Oncol Rep; 2003; 10(5):1301-5. PubMed ID: 12883697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.